Polymeric nanoparticles for cancer therapy

被引:26
作者
Parveen, Suphiya [1 ]
Sahoo, Sanjeeb K. [1 ]
机构
[1] Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India
关键词
nanoparticles; cancer; drug delivery; biodegradable polymers;
D O I
10.1080/10611860701794353
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is an ever-increasing menace that needs to be curbed soon. Though chemotherapy is successful to some extent, the main drawbacks of chemotherapy is the limited accessibility of drugs to the tumor tissues requiring high doses, their intolerable toxicity, development of multiple drug resistance and their non-specific targeting. Nanoparticles (NPs), an evolution of nanotechnology, have the potential to successfully address these problems related to drug delivery and retention and are considered potential candidates to carry drugs to the desired site of therapeutic action. In this review, we give an overview of the use of clinically applicable NPs mainly for cancer therapy. We also focus on the different types of nanoscale polymer carriers used for the delivery of chemotherapeutic agents and the mechanisms that facilitate their targeted delivery to tumor cells.
引用
收藏
页码:108 / 123
页数:16
相关论文
共 121 条
  • [51] Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel (Reprinted from Journal of Controlled Release, vol 109, pg 1, 2005)
    Kim, JH
    Kim, YS
    Kim, S
    Park, JH
    Kim, K
    Choi, K
    Chung, H
    Jeong, SY
    Park, RW
    Kim, IS
    Kwon, IC
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) : 228 - 234
  • [52] Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
    Kirpotin, Dmitri B.
    Drummond, Daryl C.
    Shao, Yi
    Shalaby, M. Refaat
    Hong, Keelung
    Nielsen, Ulrik B.
    Marks, James D.
    Benz, Christopher C.
    Park, John W.
    [J]. CANCER RESEARCH, 2006, 66 (13) : 6732 - 6740
  • [53] Paclitaxel nanoparticles for the potential treatment of brain tumors
    Koziara, JM
    Lockman, PR
    Allen, DD
    Mumper, RJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 99 (02) : 259 - 269
  • [54] Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer
    Kukowska-Latallo, JF
    Candido, KA
    Cao, ZY
    Nigavekar, SS
    Majoros, IJ
    Thomas, TP
    Balogh, LP
    Khan, MK
    Baker, JR
    [J]. CANCER RESEARCH, 2005, 65 (12) : 5317 - 5324
  • [55] Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging
    Kumagai, Michiaki
    Imai, Yutaka
    Nakamura, Teisaku
    Yamasaki, Yuichi
    Sekino, Masaki
    Ueno, Shoogo
    Hanaoka, Kenjiro
    Kikuchi, Kazuya
    Nagano, Tetsuo
    Kaneko, Eiji
    Shimokado, Kentaro
    Kataoka, Kazunori
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2007, 56 (1-2) : 174 - 181
  • [56] Nanoparticle drug delivery system for restenosis
    Labhasetwar, V
    Song, CX
    Levy, RJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 24 (01) : 63 - 85
  • [57] Labhasetwar V., 1997, PHARM NEWS, V4, P28
  • [58] Lamprecht A, 2001, J PHARMACOL EXP THER, V299, P775
  • [59] Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles
    Lee, Mi-Kyung
    Lim, Soo-Jeong
    Kim, Chong-Kook
    [J]. BIOMATERIALS, 2007, 28 (12) : 2137 - 2146
  • [60] Dextran-gold nanoparticle hybrid material for biomolecule immobilization and detection
    Lee, S
    Pérez-Luna, VH
    [J]. ANALYTICAL CHEMISTRY, 2005, 77 (22) : 7204 - 7211